ACADIA Pharmaceuticals Inc (ACAD)
16.62
+0.31
(+1.90%)
USD |
NASDAQ |
Apr 26, 15:09
ACADIA Pharmaceuticals Shares Outstanding: 164.77M for Feb. 21, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
February 21, 2024 | 164.77M |
December 31, 2023 | 164.65M |
October 25, 2023 | 164.18M |
September 30, 2023 | 163.97M |
July 26, 2023 | 163.73M |
June 30, 2023 | 163.36M |
April 26, 2023 | 162.63M |
April 14, 2023 | 162.23M |
March 31, 2023 | 162.38M |
February 21, 2023 | 162.23M |
February 16, 2023 | 162.23M |
December 31, 2022 | 162.06M |
October 21, 2022 | 161.93M |
September 30, 2022 | 161.87M |
July 28, 2022 | 161.84M |
June 30, 2022 | 161.84M |
April 28, 2022 | 161.43M |
April 22, 2022 | 161.43M |
March 31, 2022 | 161.38M |
February 28, 2022 | 161.33M |
February 15, 2022 | 161.20M |
December 31, 2021 | 161.01M |
October 25, 2021 | 160.76M |
September 30, 2021 | 160.69M |
July 28, 2021 | 160.64M |
Date | Value |
---|---|
June 30, 2021 | 160.62M |
April 27, 2021 | 160.18M |
April 26, 2021 | 160.18M |
March 31, 2021 | 160.17M |
February 28, 2021 | 160.05M |
February 10, 2021 | 160.05M |
December 31, 2020 | 159.64M |
October 22, 2020 | 158.98M |
September 30, 2020 | 158.86M |
August 24, 2020 | 158.86M |
July 22, 2020 | 157.68M |
June 30, 2020 | 157.38M |
April 24, 2020 | 155.86M |
April 22, 2020 | 155.72M |
March 31, 2020 | 155.44M |
February 07, 2020 | 155.36M |
January 31, 2020 | 155.34M |
December 31, 2019 | 155.28M |
October 23, 2019 | 154.03M |
September 30, 2019 | 153.54M |
September 20, 2019 | 151.67M |
July 24, 2019 | 144.49M |
June 30, 2019 | 144.45M |
April 29, 2019 | 144.17M |
April 24, 2019 | 144.17M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
144.17M
Minimum
Apr 29 2019
164.77M
Maximum
Feb 21 2024
159.06M
Average
160.64M
Median
Jul 28 2021
Shares Outstanding Benchmarks
Tonix Pharmaceuticals Holding Corp | 95.54M |
Amylyx Pharmaceuticals Inc | 67.78M |
Regulus Therapeutics Inc | 65.47M |
Minerva Neurosciences Inc | 6.993M |
Viking Therapeutics Inc | 110.27M |